Stay updated with breaking news from Pharma Mar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report)’s stock price was down 6.4% during mid-day trading on Friday . The company traded as low as $43.28 and last traded at $43.28. Approximately 150 shares traded hands during mid-day trading, an increase of 704% from the average daily volume of 19 shares. The stock had previously […]
Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $32.10 and last traded at $32.10, with a volume of 0 shares traded. The stock had previously closed at $32.10. Pharma Mar Stock Performance The firm’s 50-day simple moving average […]
Selpercatinib resulted in a statistically significant improvement in progression-free survival and overall response rate compared with cabozantinib or vandetanib in patients with advanced, multikinase inhibitor–naïve, RET-mutant medullary thyroid cancer, according to interim findings from the phase 3 LIBRETTO-531 trial.
Dostarlimab plus chemotherapy elicited a higher objective response rate and showcased a numerical improvement in overall survival compared with pembrolizumab and chemotherapy in patients with treatment-naïve, nonsquamous non–small cell lung cancer.
Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report)’s share price hit a new 52-week low during trading on Monday . The company traded as low as $32.10 and last traded at $32.10, with a volume of 4 shares traded. The stock had previously closed at $32.10. Pharma Mar Price Performance The stock has a 50 […]